RT @EddieRDMD: NEJM: Retrospective case-control study, n=109,254. For those aged <65yo with Covid Paxlovid had zero benefit. …

RT @EddieRDMD: NEJM: Retrospective case-control study, n=109,254. For those aged <65yo with Covid Paxlovid had zero benefit. Some benefit for >65yo. Cost might have been $1.2 million to prevent just ONE hospitalization. Journal: https://nejm.org/doi/full/10.1056/NEJMoa2204919?query=featured_home Press: https://apnews.com/article/covid-science-health-seniors-d8f6af66517054aae7fb27d1ecc6df66 @_atanas_




(Feed generated with FetchRSS)
Go to Source
Author: International Natural Product Sciences Taskforce



The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferencesgrants and funding opportunitiesjobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, biotechnology, medicine and pharmacognosy research, and natural product science.

Join for free INPST as a member

INPST social media channels



0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x